Encefalopatia hiperamonêmica associada ao valproato na hemorragia subaracnóidea: um diagnóstico a considerar

Fuellis, Vivian; Grille, Pedro; Verga, Federico; Alfaro, Luis Urbán; Grasiuso, Lucciano; Barbato, Marcelo.
Rev. bras. ter. intensiva ; 34(1): 197-201, jan.-mar. 2022. graf
Artículo en Portugués | LILACS-Express | ID: biblio-1388053

Documentos relacionados

  1. Valproate-associated hyperammonemic encephalopathy in subarachnoid hemorrhage: a diagnosis to consider.
  2. Valproate-Associated Hyperammonemic Encephalopathy: Clinical Correlates and Management Strategies in a Tertiary Care Center.
  3. [Irreversible valproate-associated liver failure].
  4. Valproic acid-induced encephalopathy: A review of clinical features, risk factors, diagnosis, and treatment.
  5. Valproate-related hyperammonemic encephalopathy with generalized suppression EEG: a case report.
  6. Levocarnitine for the Treatment of Valproic Acid-Induced Hyperammonemic Encephalopathy in Children: The Experience of a Large, Tertiary Care Pediatric Hospital and a Poison Center.
  7. Valproate-Associated Hyperammonaemic Encephalopathy.
  8. [Recommendations for blood studies and clinical monitoring in early detection of valproate-associated liver failure. Results of a consensus conferences 9 May - 11 May 1997 in Berlin].
  9. Cerebral and cerebellar pseudoatrophy associated with valproic acid. Report of three pediatric cases.
  10. Error innat del metabolisme diagnosticat després d'encefalopatia hiperamonièmica induïda per valproat